Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier

Colloids and Surfaces B: Biointerfaces

Volumn 149, Issue , 2017, Pages 301-311

  Yostawonkul, Jakarwan ^a   Surassmo, Suvimol ^a   Iempridee, Tawin ^a   Pimtong, Wittaya ^a   Suktham, Kunat ^a   Sajomsang, Warayuth ^a   Gonil, Pattarapond ^a   Ruktanonchai, Uracha Rungsardthong ^a  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Alpha mangostin; Mucoadhesive; Nanostructure lipid carrier; Oleoyl quaternized chitosan

Indexed keywords

CELL DEATH; CHITIN; CHITOSAN; CYTOTOXICITY; DISEASES; ENCAPSULATION; HOMOGENIZATION METHOD; HYDROPHOBICITY; NANOPARTICLES; POLYMERASE CHAIN REACTION; SURFACE TREATMENT; TRANSCRIPTION;

ALPHA-MANGOSTIN; EFFICIENT DRUG DELIVERY; ENCAPSULATION EFFICIENCY; HIGH PRESSURE HOMOGENIZATION; MUCOADHESIVE; NANOSTRUCTURE LIPID CARRIERS; QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; QUATERNIZED CHITOSANS;

NANOSTRUCTURES;

ALPHA MANGOSTIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; CHITOSAN; NANOCARRIER; NANOMATERIAL; NANOSTRUCTURE LIPID CARRIER; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CCND1 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DRUG CARRIER; MANGOSTIN; NANOPARTICLE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN KINASE INHIBITOR; XANTHONE DERIVATIVE;

APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CELL TRANSPORT; CELL VIABILITY; CHEMICAL MODIFICATION; CHEMICAL PROCEDURES; CONTROLLED STUDY; DISPERSITY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMBRYO; ENCAPSULATION; ENCAPSULATION EFFICIENCY; ENZYME ACTIVATION; GENE EXPRESSION; HELA CELL LINE; HOMOGENIZATION PROCESS; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MORTALITY; NONHUMAN; PARTICLE SIZE; PHYSICAL PARAMETERS; PHYSICAL STABILITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE MODIFICATION; SYNTHESIS; ZEBRA FISH; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; CACO-2 CELL LINE; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; DRUG RELEASE; GENETICS; METABOLISM; SURFACE PROPERTY; ULTRASTRUCTURE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CACO-2 CELLS; CELL SURVIVAL; CHITOSAN; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; GENE EXPRESSION; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOPARTICLES; PARTICLE SIZE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURFACE PROPERTIES; XANTHONES;

EID: 84993931348     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.09.049     Document Type: Article

References (44)

1. [1] Pawar, D., Mangal, S., Goswami, R., Jaganathan, K.S., Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur. J. Pharm. Biopharm. 85 (2013), 550–559.
2. [2] Lu, S., Xu, L., Kang, E.T., Mahendran, R., Chiong, E., Neoh, K.G., Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer. Eur. J. Pharm. Sci. 84 (2016), 103–115.
3. [3] Li, C., Liu, Z., Yan, X., Lu, W., Liu, Y., Mucin-controlled drug release from mucoadhesive phenylboronic acid-rich nanoparticles. Int. J. Pharm. 479 (2015), 261–264.
4. [4] Andreani, T., Miziara, L., Lorenzón, E.N., de Souza, A.L.R., Kiill, C.P., Fangueiro, J.F., Garcia, M.L., Gremião, P.D., Silva, A.M., Souto, E.B., Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: interactions with mucin and biomembrane models. Eur. J. Pharm. Biopharm. 93 (2015), 118–126.
5. [5] Mythri, K.K., Rupesh Kumar, G.M., Jagadeesh Singh, S.d., Novel mucoadhesive polymers −a review. J. Appl. Pharm. Sci. 08 (2011), 37–42.
6. [6] Grabovac, V., Guggi, D., Bernkop-Schnürch, A., Comparison of the mucoadhesive properties of various polymers. Adv. Drug Delivery Rev. 57 (2005), 1713–1723.
7. [7] Salamat-Miller, N., Chittchang, M., Johnston, T.P., The use of mucoadhesive polymers in buccal drug delivery. Adv. Drug Delivery Rev. 57 (2005), 1666–1691.
8. [8] Lu, S., Neoh, K.G., Kang, E.-T., Mahendran, R., Chiong, E., Mucoadhesive polyacrylamide nanogel as a potential hydrophobic drug carrier for intravesical bladder cancer therapy. Eur. J. Pharm. Sci. 72 (2015), 57–68.
9. [9] Costa, I.S.M., Abranches, R.P., Garcia, M.T., Pierre, M.B., Chitosan-based mucoadhesive films containing 5-aminolevulinic acid for buccal cancer's treatment. J. Photochem. Photobiol. B Biol. 140 (2014), 266–275.
10. [10] Berginc, K., Suljakovic, S., Skalko-Basnet, N., Kristl, A., Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin. Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 87 (2014), 40–46.
11. [11] Ravi Kumar, M.N.V., A review of chitin and chitosan applications. React. Funct. Polym. 46 (2000), 1–27.
12. [12] Fonte, P., Nogueira, T., Gehm, C., Ferreira, D., Sarmento, B., Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Delivery Transl. Res. 1 (2011), 299–308.
13. [13] Luo, Y., Teng, Z., Li, Y., Wang, Q., Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr. Polym. 122 (2015), 221–229.
14. [14] Müller, R.H., Petersen, R.D., Hommoss, A., Pardeike, J., Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Delivery Rev. 59 (2007), 522–530.
15. [15] Wang, Y.W., Jou, C.H., Hung, C.C., Yang, M.C., Cellular fusion and whitening effect of a chitosan derivative coated liposome. Colloids Surf. B Biointerfaces 90 (2012), 169–176.
16. 4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater. Sci. Eng. C Mater. Biol. Appl. 48 (2015), 487–498.
17. [17] Sosnik, A., das Neves, J., Sarmento, B., Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review. Prog. Polym. Sci. 39 (2014), 2030–2075.
18. [18] Ying, X.Y., Cui, D., Yu, L., Du, Y.Z., Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin. Carbohydr. Polym. 84 (2011), 1357–1364.
19. [19] Luo, Q., Zhao, J., Zhang, X., Pan, W., Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int. J. Pharm. 403 (2011), 185–191.
20. [20] Gartziandia, O., Herran, E., Pedraz, J.L., Carro, E., Igartua, M., Hernandez, R.M., Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration. Colloids Surf. B: Biointerfaces 134 (2015), 304–313.
21. [21] Müller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Delivery Rev. 54:Suppl (2002), S131–S155.
22. [22] Li, S., Su, Z., Sun, M., Xiao, Y., Cao, F., Huang, A., Li, H., Ping, Q., Zhang, C., An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery. Int. J. Pharm. 436 (2012), 248–257.
23. [23] Pedraza-Chaverri, J., Cárdenas-Rodríguez, N., Orozco-Ibarra, M., Pérez-Rojas, J.M., Medicinal properties of mangosteen (Garcinia mangostana). Food Chem. Toxicol. 46 (2008), 3227–3239.
24. [24] Nakagawa, Y., Iinuma, M., Naoe, T., Nozawa, Y., Akao, Y., Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg. Med. Chem. 15 (2007), 5620–5628.
25. [25] Won, Y.S., Lee, J.H., Kwon, S.J., Kim, J.Y., Park, K.H., Lee, M.K., Seo, K.I., α-Mangostin-induced apoptosis is mediated by estrogen receptor α in human breast cancer cells. Food Chem. Toxicol. 66 (2014), 158–165.
26. [26] Sashiwa, H., Shigemasa, Y., Roy, R., Chemical modification of chitosan 8: preparation of chitosan–dendrimer hybrids via short spacer. Carbohydr. Polym. 47 (2002), 191–199.
27. [27] Smart, J.D., The basics and underlying mechanisms of mucoadhesion. Adv. Drug Delivery Rev. 57 (2005), 1556–1568.
28. [28] Chaleawlert-umpon, S., Nuchuchua, O., Saesoo, S., Gonil, P., Ruktanonchai, U.R., Sajomsang, W., Pimpha, N., Effect of citrate spacer on mucoadhesive properties of a novel water-soluble cationic β-cyclodextrin-conjugated chitosan. Carbohydr. Polym. 84 (2011), 186–194.
29. [29] Rossi, S., Ferrari, F., Bonferoni, M.C., Caramella, C., Characterization of chitosan hydrochloride–mucin rheological interaction: influence of polymer concentration and polymer:mucin weight ratio. Eur. J. Pharm. Sci. 12 (2001), 479–485.
30. [30] Surassmo, S., Saengkrit, N., Ruktanonchai, U.R., Suktham, K., Woramongkolchai, N., Wutikhun, T., Puttipipatkhachorn, S., Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization. Colloids Surf. B: Biointerfaces 130 (2015), 229–236.
31. [31] Sun, L., Wu, Q., Peng, F., Liu, L., Gong, C., Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy. Colloids Surf. B: Biointerfaces 135 (2015), 56–72.
32. [32] Xu, W., Jin, W., Li, Z., Liang, H., Wang, Y., Shah, B.R., Li, Y., Li, B., Synthesis and characterization of nanoparticles based on negatively charged xanthan gum and lysozyme. Food Res. Int. 71 (2015), 83–90.
33. [33] Dai, Y.J., Jia, Y.F., Chen, N., Bian, W.P., Li, Q.K., Ma, Y.B., Chen, Y.L., Pei, D.S., Zebrafish as a model system to study toxicology. Environ. Toxicol. Chem. SETAC 33 (2014), 11–17.
34. [34] Rennekamp, A.J., Peterson, R.T., 15 years of zebrafish chemical screening. Curr. Opin. Chem. Biol. 24 (2015), 58–70.
35. [35] Blackburn, J.S., Langenau, D.M., Zebrafish as a model to assess cancer heterogeneity, progression and relapse. Dis. Models Mech. 7 (2014), 755–762.
36. [36] Bohnsack, J.P., Assemi, S., Miller, J.D., Furgeson, D.Y., The primacy of physicochemical characterization of nanomaterials for reliable toxicity assessment: a review of the zebrafish nanotoxicology model. Methods Mol. Biol. (Clifton, N.J.) 926 (2012), 261–316.
37. [37] Lin, S., Zhao, Y., Nel, A.E., Lin, S., Zebrafish: an in vivo model for nano EHS studies. Small 9 (2013), 1608–1618.
38. [38] Girigoswami, K., Viswanathan, M., Murugesan, R., Girigoswami, A., Studies on polymer-coated zinc oxide nanoparticles: UV-blocking efficacy and in vivo toxicity. Mater. Sci. Eng. C Mater. Biol. Appl. 56 (2015), 501–510.
39. [39] Hu, Y.L., Qi, W., Han, F., Shao, J.Z., Gao, J.Q., Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int. J. Nanomed. 6 (2011), 3351–3359.
40. [40] Rizzo, L.Y., Golombek, S.K., Mertens, M.E., Pan, Y., Laaf, D., Broda, J., Jayapaul, J., Mockel, D., Subr, V., Hennink, W.E., Storm, G., Simon, U., Jahnen-Dechent, W., Kiessling, F., Lammers, T., In vivo nanotoxicity testing using the zebrafish embryo assay. J. Mater. Chem. B Mater. Biol. Med. 1 (2013), 3918–3925.
41. [41] Shan, T., Ma, Q., Guo, K., Liu, J., Li1, W., Wang, F., Wu, E., Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Curr. Mol. Med. 11 (2011), 666–677.
42. [42] Fei, X., Jo, M., Lee, B., Han, S.B., Lee, K., Jung, J.K., Seo, S.Y., Kwak, Y.S., Synthesis of xanthone derivatives based on a-mangostin and their biological evaluation for anti-cancer agents. Bioorg. Med. Chem. Lett. 24 (2014), 2062–2065.
43. [43] Zeng, P., Xu, Y., Zeng, C., Ren, H., Penga, M., Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int. J. Pharm. 415 (2011), 259–266.
44. [44] Alqahtani, S., Simon, L., Astete, C.E., Alayoubi, A., Sylvester, P.W., Nazzal, S., Shen, Y., Xu, Z., Kaddoumi, A., Sabliov, C.M., Cellular uptake, antioxidant and antiproliferative activity of entrapped a-tocopherol and c-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi). J. Colloid Interface Sci. 445 (2015), 243–251.